Factory Sells NONAPEPTIDE-1 158563-45-2, Chinese Manufacturer Supply with Best Price
- Molecular Formula:C61H87N15O9S
- Molecular Weight:1206.5
- PKA:13.32±0.46(Predicted)
- PSA：413.34000
- Density:1.38±0.1 g/cm3(Predicted)
- LogP:6.21360
NONAPEPTIDE-1 (Cas 158563-45-2) Usage
NONAPEPTIDE-1 is a synthetic peptide that has been used in skincare products for its ability to brighten and even out skin tone. It works by inhibiting the production of melanin, the pigment that gives our skin its color, and is often used in products designed to reduce the appearance of dark spots and hyperpigmentation. In addition to its brightening effects, NONAPEPTIDE-1 has also been shown to have antioxidant properties, making it a popular ingredient in anti-aging skincare formulations. Overall, NONAPEPTIDE-1 is a versatile ingredient that can help improve the appearance of skin tone and texture, making it a valuable addition to many skincare products.
InChIKey: KNFLNGRLKALWRF-LDXSYGEZSA-N
InChI: InChI=1S/C61H87N15O9S/c1-37(2)51(52(64)77)74-58(83)50-26-16-31-76(50)60(85)45(23-12-13-28-62)70-55(80)46(33-38-17-6-4-7-18-38)71-56(81)48(35-40-36-68-43-22-11-10-21-41(40)43)72-53(78)44(24-14-29-67-61(65)66)69-54(79)47(34-39-19-8-5-9-20-39)73-57(82)49-25-15-30-75(49)59(84)42(63)27-32-86-3/h4-11,17-22,36-37,42,44-51,68H,12-16,23-35,62-63H2,1-3H3,(H2,64,77)(H,69,79)(H,70,80)(H,71,81)(H,72,78)(H,73,82)(H,74,83)(H4,65,66,67)/t42-,44-,45-,46-,47+,48+,49-,50-,51-/m0/s1
158563-45-2 Relevant articles
Iodination of angiotensin I, nonapeptide (1-9), angiotensin II, heptapeptide (2-8), hexapeptide (3-8) and pentapeptide (4-8)
Damkjaer Nielsen, M. (Glostrup Sygehus, Copenhagen (Denmark)); Kappelgaard, A.M. (Glostrup Sygehus, Copenhagen (Denmark)); Giese, J. (Glostrup Sygehus, Copenhagen (Denmark))
, Sep 1975; 4 p; Quality factors in nuclear medicine.
-
The outstanding metabolic stability of a 14C-labeled β-nonapeptide in rats – in vitro and in vivo pharmacokinetic studies
Hansjörg Wiegand, Bernard Wirz, Alain Schweitzer, Gian P. Camenisch, Maria I. Rodriguez Perez, Gerhard Gross, Ralph Woessner, Rolf Voges, Per I. Arvidsson, Jens Frackenpohl, Dieter Seebach
, Biopharmaceutics & Drug Disposition, Volume23, Issue6 September 2002 Pages 251-262
… and human blood was spiked with [14C]b-nonapeptide 1 to get final concentrations of 5, 50, 500 … The concentration of [14C]b-nonapeptide 1 was determined in the ultrafiltrate and in the …
A randomized controlled pilot study of a proprietary combination versus sunscreen in melasma maintenance
Manas Chatterjee, Shekhar Neema1, Gopalsing Rameshsing Rajput
, Indian Journal of Dermatology, Venereology and Leprology
Thereafter, the case group received the study formulation i.e.,phenyl ethyl resorcinol, nonapeptide-1, aminoethyl phosphinic acid, antioxidants andsunscreen for 16 weeks to be applied in the morning and afternoon at 08:00 hours and 14:00 hours and the control group received the placebo i.e.,sunscreen to be applied at the same times. The total number of visits during phase 2 was 4 (visit 4, visit 5, visit 6 and visit 7) with an interval of 4 weeks ± 3 days.
